Clinical trial
Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E…
NCT00220831 · Technion, Israel Institute of Technology, Other · Terminated
Key facts
| NCT number | NCT00220831 |
|---|---|
| Title | Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment |
| Official title | Prevention of Diabetic Cardiovascular Complications With Vitamin E 400 IU Treatment to High Risk Patients by Haptoglobin Phenotype (I CARE - Israel Cardiovascular Atherosclerosis Risk and Vitamin E) |
| Lead sponsor | Technion, Israel Institute of Technology, Other |
| Collaborators | Clalit Health Services The Kennedy Leigh Charitable Trust |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Myocardial Infarction, Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | Natural source Vitamin E 400IU/day |
| Enrollment | 2,000 |
| Start date | Apr 1, 2005 |
| Completion | Dec 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 1, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: